RU2002113757A - Imidazolpyridine derivatives as phosphodiesterase VII inhibitors - Google Patents
Imidazolpyridine derivatives as phosphodiesterase VII inhibitorsInfo
- Publication number
- RU2002113757A RU2002113757A RU2002113757/04A RU2002113757A RU2002113757A RU 2002113757 A RU2002113757 A RU 2002113757A RU 2002113757/04 A RU2002113757/04 A RU 2002113757/04A RU 2002113757 A RU2002113757 A RU 2002113757A RU 2002113757 A RU2002113757 A RU 2002113757A
- Authority
- RU
- Russia
- Prior art keywords
- solvates
- carbon atoms
- acceptable salts
- formula
- physiologically acceptable
- Prior art date
Links
- 239000002606 phosphodiesterase VII inhibitor Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims 5
- 125000004432 carbon atoms Chemical group C* 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 208000006673 Asthma Diseases 0.000 claims 2
- 206010003816 Autoimmune disease Diseases 0.000 claims 2
- 206010006451 Bronchitis Diseases 0.000 claims 2
- 206010006458 Bronchitis chronic Diseases 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 2
- 208000007451 Chronic Bronchitis Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010011401 Crohn's disease Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 2
- 208000006641 Skin Disease Diseases 0.000 claims 2
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 2
- 201000001320 atherosclerosis Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 200000000018 inflammatory disease Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 201000004681 psoriasis Diseases 0.000 claims 2
- 230000004614 tumor growth Effects 0.000 claims 2
- 201000006704 ulcerative colitis Diseases 0.000 claims 2
- 241000195622 Astasia Species 0.000 claims 1
- 206010010947 Coordination abnormal Diseases 0.000 claims 1
- 208000001652 Memory Disorders Diseases 0.000 claims 1
- 206010027175 Memory impairment Diseases 0.000 claims 1
- 206010027476 Metastasis Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 101710031992 pRL90232 Proteins 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 101710035540 plaa2 Proteins 0.000 claims 1
Claims (6)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19953414.4 | 1999-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2002113757A true RU2002113757A (en) | 2003-12-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10842792B2 (en) | Deuterated baricitinib | |
ES2461967T3 (en) | Pyrrolo [2,3-d] pyrimidine compounds | |
ES2543216T3 (en) | Thiazolopyrimidine modulators as immunosuppressive agents | |
TWI424999B (en) | Azaindoles useful as inhibitors of janus kinases | |
RU2665680C2 (en) | Bisulfate of janus kinaze (jak) inhibitor and method for its preparation | |
JP2010502716A (en) | Modulator of interleukin 1 receptor related kinase | |
ZA200604970B (en) | Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE 2 inhibitors | |
CA2160928A1 (en) | Compounds as pde iv and tnf inhibitors | |
EA023646B1 (en) | SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-c]QUINAZOLINE SALTS | |
EA022527B1 (en) | 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF | |
RU2002113750A (en) | Derivatives of pyrrole as phosphodiesterase VII inhibitors | |
EP4025575A1 (en) | Rip1 inhibitory compounds and methods for making and using the same | |
EP1902054B1 (en) | Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof and the therapeutic application of the same | |
RU2002113759A (en) | Imidazole compounds as phosphodiesterase VII inhibitors | |
EP2804863B1 (en) | New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor | |
JP2001510843A5 (en) | ||
KR20190035755A (en) | Heterocyclic compounds as JAK inhibitors, and salts thereof and therapeutic uses | |
JP2002537258A5 (en) | ||
BR112021006033A2 (en) | USE OF AN INHIBITOR OF A TRANSPORTER OF THE ENT FAMILY IN THE TREATMENT OF CANCER AND COMBINATION OF THE SAME WITH AN ADENOSINE RECEPTOR ANTAGONIST | |
JP2020531574A (en) | Compounds, their pharmaceutical compositions and their uses and applications | |
CN113214230B (en) | 2-substituted pyrazol amino-4-substituted amino-5-pyrimidine formamide compound, composition and application thereof | |
JP2023506118A (en) | Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and lichen planus (LP) | |
TW202327611A (en) | Methods of cancer treatment using a combination of btk inhibitors and pi3 kinase inhibitors | |
RU2002113757A (en) | Imidazolpyridine derivatives as phosphodiesterase VII inhibitors | |
KR20000035869A (en) | Preventives/remedies for muscle tissue degenerations |